Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/use-of-cannabinoids-for-the-treatment-of-osa-GtOLWnPABo
References (34)
-
Y. Subramani, Mandeep Singh, J. Wong, C. Kushida, A. Malhotra, F. Chung (2017)
Understanding Phenotypes of Obstructive Sleep Apnea: Applications in Anesthesia, Surgery, and Perioperative MedicineAnesthesia & Analgesia, 124
-
P. Whiting, P. Whiting, R. Wolff, Sohan Deshpande, M. Nisio, S. Duffy, A. Hernandez, A. Hernandez, J. Keurentjes, S. Lang, K. Misso, S. Ryder, Simone Schmidlkofer, M. Westwood, J. Kleijnen (2015)
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.JAMA, 313 24
-
D. Carley, M. Radulovacki (1999)
Role of peripheral serotonin in the regulation of central sleep apneas in rats.Chest, 115 5
-
Douglas Hanzel, Nicholas Proia, Nicholas Proia, D. Hudgel, D. Hudgel (1991)
Response of obstructive sleep apnea to fluoxetine and protriptyline.Chest, 100 2
-
S. Farabi, B. Prasad, L. Quinn, D. Carley (2014)
Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 10 1
-
Michael Calik, M. Radulovacki, D. Carley (2014)
Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley ratRespiratory Physiology & Neurobiology, 190
-
M. Glass, R. Faull, M. Dragunow (1997)
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brainNeuroscience, 77
-
D. Carley, Sasa Paviovic, M. Janelidze, M. Radulovacki (2002)
Functional role for cannabinoids in respiratory stability during sleep.Sleep, 25 4
-
H. Kraiczi, J. Hedner, P. Dahlöf, H. Ejnell, J. Carlson (1999)
Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea.Sleep, 22 1
-
Sean Brown, J. Wager-Miller, K. Mackie (2002)
Cloning and molecular characterization of the rat CB2 cannabinoid receptor.Biochimica et biophysica acta, 1576 3
-
B. Prasad, M. Radulovacki, D. Carley (2013)
Proof of Concept Trial of Dronabinol in Obstructive Sleep ApneaFrontiers in Psychiatry, 4
-
Michael Calik, D. Carley (2016)
Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley ratsJournal of Negative Results in Biomedicine, 15
-
B. Kopczyńska (2007)
The contribution of VR1 and CB1 receptors and the role of the afferent vagal pathway in modelling of cardio-respiratory effects of anandamide in rats.Life sciences, 80 19
-
W. Randerath, J. Verbraecken, S. Andreas, G. Bettega, A. Boudewyns, E. Hamans, F. Jalbert, J. Paoli, Bernd Sanner, I. Smith, B. Stuck, L. Lacassagne, M. Marklund, J. Maurer, J. Pépin, A. Valipour, T. Verse, I. Fietze (2011)
Non-CPAP therapies in obstructive sleep apnoeaEuropean Respiratory Journal, 37
-
Anastasia Suraev, N. Marshall, R. Vandrey, D. McCartney, M. Benson, I. McGregor, R. Grunstein, C. Hoyos (2020)
Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies.Sleep medicine reviews, 53
-
S. Munro, K. Thomas, Muna Abu-Shaar (1993)
Molecular characterization of a peripheral receptor for cannabinoidsNature, 365
-
Ran Abuhasira, L. Shbiro, Yuval Landschaft (2018)
Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America.European journal of internal medicine, 49
-
R. Pertwee (2006)
The pharmacology of cannabinoid receptors and their ligands: an overviewInternational Journal of Obesity, 30
-
D. Carley, B. Prasad, K. Reid, R. Malkani, H. Attarian, Sabra Abbott, B. Vern, Hui Xie, C. Yuan, P. Zee (2018)
Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep ApneaSLEEP, 41
-
D. Eckert, D. White, A. Jordan, A. Malhotra, A. Wellman (2013)
Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.American journal of respiratory and critical care medicine, 188 8
-
(2017)
zsx112 This animal study showed positive effects on cannabinoid agonist on sleep apnea, with reduction in apneic events with injection of dronabinol -
Kimberly Babson, James Sottile, Danielle Morabito (2017)
Cannabis, Cannabinoids, and Sleep: a Review of the LiteratureCurrent Psychiatry Reports, 19
-
Brant Hasler, L. Kirisci, D. Clark (2016)
Restless Sleep and Variable Sleep Timing During Late Childhood Accelerate the Onset of Alcohol and Other Drug Involvement.Journal of studies on alcohol and drugs, 77 4
-
N. Volkow, R. Baler, W. Compton, S. Weiss (2014)
Adverse health effects of marijuana use.The New England journal of medicine, 370 23
-
have been highlighted as: • Of importance •• Of major importance 1 -
L. Kubin, H. Tojima, R. Davies, A. Pack (1992)
Serotonergic excitatory drive to hypoglossal motoneurons in the decerebrate catNeuroscience Letters, 139
-
B. Prasad, M. Radulovacki, C. Olopade, J. Herdegen, T. Logan, D. Carley (2010)
Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome.Sleep, 33 7
-
D. Smith, T. lee-chiong (2008)
Respiratory Physiology During SleepSleep Medicine Clinics, 3
-
Michael Calik, D. Carley (2017)
Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley RatsSLEEP, 40
-
Identification functional characterization of brainstem cannabinoid CB2 receptors. -
K. Ramar, I. Rosen, D. Kirsch, R. Chervin, K. Carden, R. Aurora, D. Kristo, R. Malhotra, Jennifer Martin, E. Olson, C. Rosen, J. Rowley (2018)
Medical Cannabis and the Treatment of Obstructive Sleep Apnea: An American Academy of Sleep Medicine Position Statement.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 14 4
-
Raissa Aoun, H. Rawal, H. Attarian, A. Sahni (2019)
Impact of traumatic brain injury on sleep: an overview -
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations -
R. Jumpertz, Tobias Wiesner, Matthias Blüher, S. Engeli, S. Batkai, H. Wirtz, A. Bosse-Henck, Michael Stumvoll (2010)
Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 118 9
- Publisher
- Springer Journals
- Copyright
- Copyright © Springer Nature Switzerland AG 2020
- eISSN
- 2198-6401
- DOI
- 10.1007/s40675-020-00192-w
- Publisher site
- See Article on Publisher Site
Abstract
Purpose of ReviewObstructive sleep apnea (OSA) is associated with increased risk of morbidity and mortality. Positive airway pressure (PAP) therapy remains the gold standard treatment, but its use is often limited by patient compliance, hence the need to consider other potential therapies. Preliminary data may suggest potential role of cannabinoids in the treatment of OSA. We aim to summarize the current knowledge on cannabinoid use and its impact on the pathophysiology of OSA as well as its role as a potential management option.Recent FindingsRecently, a phase II placebo-controlled trial of dronabinol reported dose-dependent reduction in the apnea-hypopnea index (AHI). A phase III trial exploring this link further is planned.SummaryCannabinoid use has variable effects in the treatment of OSA. Preliminary data are promising but insufficient regarding both efficacy and safety. Further research is needed to understand its role in management of OSA.
Journal
Current Sleep Medicine Reports – Springer Journals
Published: Nov 16, 2020